20250230245. Fusion Poly (ADLAI NORTYE BIOPHARMA ., .)
A FUSION POLYPEPTIDE AND ITS USE
Abstract: the present application relates to a fusion polypeptide and its use. specifically, the fusion polypeptide of the present application can block pd-1/pd-l1 signaling and/or can have the function of activating an immune response. the application also provides the use of the polypeptide.
Inventor(s): Nanhai HE, Youping WANG, Wenjing YANG, Wanwan CHEN
CPC Classification: C07K16/2827 (PEPTIDES (peptides in foodstuffs ; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs ; preparations for medicinal purposes ; peptides containing beta-lactam rings ; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, ; ergot alkaloids of the cyclic peptide type ; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids ; macromolecular products derived from proteins ; preparation of glue or gelatine ; single cell proteins, enzymes ; genetic engineering processes for obtaining peptides ; compositions for measuring or testing processes involving enzymes ; investigation or analysis of biological material ))
Search for rejections for patent application number 20250230245